baber/WOPTO huggingface dataset:
Patent NZ-550613-A (NZ)
Title: Powered watercraft
Inventor: ROBINSON CHARLES W
IPC: B63B1/38
Filed: 2005-09-28
Abstract: A watercraft, comprising at least one hull having at least one planing surface, at least one vertical step in the planing surface, an onboard propulsion engine 106, and means 108 for venting exhaust from the onboard propulsion engine 106 at the vertical step in the planing surface while under way in order to introduce gas along the planing surface, the means for venting exhaust including means for venting a first proportion of the exhaust 108A at the vertical step in the planing surface, including a first exhaust conduit 108 that defines a first exhaust flow path 108A leading to the vertical step in the planing surface, and the means for venting exhaust including means for venting a second proportion of the exhaust to atmosphere, including a second exhaust conduit 109 that defines a second exhaust flow path 109A leading to atmosphere, wherein the onboard propulsion engine 106 is not an internal combustion engine with multiple cylinders exhausting through a corresponding number of exhaust ports at the underside.
Patent NZ-554342-A (NZ)
Title: Method of preparing modified diallyl-N,N-disubstituted ammonium halide polymers
Inventor: SHING JANE WONG B
IPC: C08F4/00
Filed: 2005-10-15
Abstract: Disclosed is a method of preparing a modified diallyl-N,N-disubstituted ammonium halide polymer having a cationic charge of about 1 to about 99 mole percent and a RSV of from about 0.2 to about 12 dL/g and a charge density of less than about 7 milliequivalents/g polymer comprising: (a) preparing an aqueous solution comprising one or more diallyl-N,N-disubstituted ammonium halide monomers, about 35 to about 85 percent of the total acrylamide monomer, about 0.1 to about 150,000 ppm based on monomer of one or more chain transfer agents (such as sodium formate or sodium hypophosphite), and optionally about 1 to about 30,000 ppm based on monomer of one or more cross-linking agents (such as N,N-methylenebisacrylamide); (b) initiating polymerization of the monomers; (c) allowing the polymerization to proceed to at least about 5 percent diallyl-N,N-disubstituted ammonium halide monomer conversion and at least about 20 percent acrylamide monomer conversion; and (d) adding the remaining acrylamide monomer and allowing the polymerization to proceed to the desired endpoint. Also disclosed is a method of increasing retention and drainage in a papermaking furnish comprising adding to the furnish an effective amount of a modified diallyl-N,N-disubstituted ammonium halide polymer prepared according to the above method and an effective amount of one or more high molecular weight, water-soluble cationic, anionic, nonionic, zwitterionic or amphoteric polymer flocculants.
Patent NZ-556126-A (NZ)
Title: Antibodies against il-13 receptor alpha 1 and uses thereof
Inventor: ENDL JOSEF
Filed: 2006-01-02
Abstract: Disclosed is an antibody binding to IL-13R alpha 1 and inhibiting IL-13, characterized in that the variable heavy chain amino acid sequence CDR3 of said antibody is selected from the group consisting of the heavy chain CDR3 sequences of SEQ ID NO: 1, 3, 5, 7 or 9.
Patent NZ-561993-A (NZ)
Title: Spiroazabicyclic heterocyclic amines as potent ligands for nicotinic acetylcholine receptors
Inventor: CHANG HUI-FANG
IPC: A61P25/34
Filed: 2003-04-15
Abstract: Disclosed are spiroazabicyclic heterocyclic amines of formula (I) and pharmaceutically acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, wherein the variables shown in formula (I) are as defined in the specification.
Patent NZ-566216-A (NZ)
Title: Tile cutting machine with light source
Inventor: GIFFORD ROBERT H
Filed: 2008-02-26
Abstract: A tile cutting machine is discloses with a tub for water and a tile supporting surface located in the tub. A cutting head assembly is positioned above the tile supporting surface and is movable relative to it. The head assembly has a laser or light source, for respectively indicating a line of cut to the tile, and illumination of the supporting surface.
Patent NZ-566318-A (NZ)
Title: Polyurethane light guides with one coloured and one transparent co-linear parts for optical effects
Inventor: JOSEPH EDMOND KENNETH
IPC: A63H33/22
Filed: 2006-09-15
Abstract: An optical illumination device is disclosed. The device is a light guide (10) formed from an unclad, flexible polyurethane fibre. The fibre has a transparent polyurethane region (14 or 16) and an adjacent coloured polyurethane region (16 or 14). These may be concentric or co-linear. At least one illumination module (22) is coupled to at least one end of the light guide, the illumination module comprising at least one light source (24) for illuminating the light guide (10).
Patent NZ-566394-A (NZ)
Title: Trail receptor 2 polypeptides and antibodies
Inventor: GLINIAK BRIAN
IPC: C12N15/13
Filed: 2006-08-28
Abstract: Disclosed is an isolated antibody comprising a heavy chain and a light chain, wherein the heavy chain comprises CDR1 having amino acids 26 to 37 of SEQ ID NO: 30, CDR2 having amino acids 52 to 67 of SEQ ID NO: 30, and CDR3 having amino acids 100 to 111 of SEQ ID NO: 30, wherein the light chain comprises CDR1 having amino acids 24 to 35 of SEQ ID NO: 64, CDR2 having amino acids 51 to 57 of SEQ ID NO: 64, and CDR3 having amino acids 90 to 98 of SEQ ID NO: 64, and wherein the antibody binds TRAIL receptor-2 (TR-2). Also disclosed is the use of the antibody in the manufacture of a medicament for treating cancer in a patient.
Patent NZ-566524-A (NZ)
Title: Isoquinolines as IGF-1R inhibitors
Inventor: GUNZINGER JAN
IPC: A61K31/472
Filed: 2006-09-08
Abstract: Disclosed is an 1,2,3,4-tetrahydroisoquinoline of the following general formula (I) wherein, R1, R2, R3, R4. R6, R7, R8, R3', R5' U, V and W are as defined in the specification and pharmaceutically acceptable salts thereof. Also disclosed is the use of said isoquinilone in the treatment of a disease in which down-regulation or inhibition of the expression or function of the IGF-1 receptor is beneficial e.g. cancer and psoriasis and compositions comprising said isoquinilone.
Patent NZ-567765-A (NZ)
Title: Device and method for cooking food on a grill between two platens, where the distance between the platens is varied during coking
Inventor: CALZADA MANUEL
IPC: A47J37/06
Filed: 2006-10-03
Abstract: A method of cooking in a plurality of stages a food product 80 having a nominal initial uncooked thickness, comprises placing the food product 80 between two opposed platens 16 18, where each opposed platen has a cooking surface and the gap 30a between the opposed cooking surfaces is adjustable. The gap 30a is adjusted so that during at least one portion of an initial stage of the cooking the gap 30b is less than the nominal initial uncooked thickness of the food product 80 and during at least one subsequent stage the gap 30c is increased so that it is greater than the smallest gap 30b in the prior stage but is still less than the nominal initial uncooked thickness of the food product 80.
Patent NZ-568034-A (NZ)
Title: Aluminium hydrate pigments with dyes and polymer composites formed thereof
Inventor: MIRLEY CHRISTOPHER L
IPC: C08K9/04
Filed: 2006-11-07
Abstract: Disclosed herein is a pigment comprising an alumina hydrate particulate material and a dye, the dye being directly covalently bonded to an oxygen atom on the surface of the alumina hydrate particulate material. Also discloses is a composite material comprising said pigment and a polymer matrix and methods for preparing said pigment.
Patent NZ-568159-A (NZ)
Title: Mask assembly
Inventor: DAVIDSON AARON SAMUEL
IPC: A61M16/06
Filed: 2008-05-12
Abstract: A mask assembly adapted for use with a positive airway pressure device, comprising: a frame; a cushion provided to the frame; a forehead support assembly; and a neck to connect the frame to the forehead support assembly, wherein the neck includes a plurality of side walls; and at least one open space between the side walls, wherein the plurality of side walls diverge from one another at a first end and a second end of the neck.
Patent NZ-568590-A (NZ)
Title: Tile cutting machine with a moveable removeable cutting device
Inventor: GIFFORD ROBERT H
Filed: 2008-02-26
Abstract: This discloses a tile cutting machine 10 having a removable cutting device 14. The tile cutting machine comprises a first rail 84', a casing 92 coupled with the first rail and movable along it, and a cutting device 14' having a motor 108 and a blade, where the blade is operationally coupled to the motor and the cutting device 14', is selectively and removably coupled with the casing 92. The blade is movable along a cutting path that is perpendicular to the first rail 84' when the cutting device 14' is coupled with the casing 92.
Patent NZ-575370-A (NZ)
Title: Polyphenol extraction process
Inventor: WOOD RICHARD
IPC: A23L5/40
Filed: 2007-08-08
Abstract: Disclosed is a process for extracting one or more polyphenols from an apple which comprises the steps of: (a) removing the coating of the apple; (b) freeze-drying or freezing the apple obtained in step (a); (c) optionally powdering the freeze-dried or frozen material obtained in step (b); (d) subjecting the material obtained in step (b) or step (c) to one or more solvent extraction cycles; and optionally thereafter (e) isolating one or more polyphenols from the liquid extract obtained in step (d). Also disclosed is a polyphenol containing extract obtained by the process as defined and the use of a polyphenol extract obtained by the process as defined in the manufacture of a medicament for use in reducing arterial stiffness.
Patent NZ-583293-A (NZ)
Title: Public collaboration system
Inventor: MEEK CRAIG ALEXANDER
IPC: H04N7/15
Filed: 2011-02-24
Abstract: A video conference or meeting data storage and management system and a method of presenting a video conference or meeting management information are disclosed. The A video conference or meeting data storage and management system includes a) a video conference data storage system storing information to be presented or being presented at a video conference or meeting, b) a conference participant information system storing information relating to persons participating in the video conference or meeting, c) a video conference control management system setting the order of presentation of presenters at a video conference or meeting and associating with the presenter the information to be presented by the presenter, d) a video conference or meeting stream providing information relating to the video conference or meeting and including displayable information including a participant icon display orderable to indicate the relevance of the participant to the conference and e) a conference recording system providing a record of proceedings at the conference or meeting. The video conference control management system may be controlled by a host, moderator or chairman of a video conference or meeting in real time and the system is characterised in that the participant icon display provides an icon for at least one of the host, moderator or chairman, that this icon is positioned in a known position within the participant icon display, that icons for the current and subsequent speakers are ordered in presentation order adjacent the icon for the host, moderator or chairman with icons for other participants ordered elsewhere in the icon display, which display is scrollable in a manner allowing viewing of all icons.
Patent NZ-585824-A (NZ)
Title: Process and device for generating middle distillate from hydrocarbonaceous energy sources
Inventor: TSCHIRNER ERHARD
IPC: C01G1/08
Filed: 2008-12-22
Abstract: Disclosed is a process for generating middle distillate from hydro-carbonaceous energy sources, which comprises the steps of: feeding at least one hydrocarbonaceous energy source, at least one catalyst and optionally at least one additive to a reactor containing a process oil mixture; conducting a first process oil mixture stream from the reactor into a pre-reactor having a mixing device; feeding the hydrocarbonaceous energy source, at least one catalyst and optionally at least one additive to the prereactor and mixing the energy source, the catalyst and, optionally, the additive with the first process oil mixture in the prereactor to form a hydrocarbon-rich, second process oil mixture; recirculating the hydrocarbon-rich, second process oil mixture from the prereactor to the reactor heating a third process oil mixture stream removed from the reactor to a process temperature between 150 degrees Celsius and 400 degrees Celsius by way of a main energy input via indirect heat transfer from a heat carrier to the third process oil mixture stream in at least one static mixer having an integrated heat transfer device; feeding the heated process oil mixture stream to a degasser and eliminating a vaporous middle distillate from the heated process oil mixture stream in the degasser; and recirculating a process oil mixture stream relieved of the vaporous middle distillate from the degasser to the process oil mixture in the reactor.
Patent NZ-594741-A (NZ)
Title: Specific diarylhydantoin and diarylthiohydantoin compounds
Inventor: JAIN RAJENDRA PARASMAL
IPC: A61K31/03
Filed: 2010-02-24
Abstract: 594741 The disclosure relates to compositions, such as pharmaceutical compositions, comprising specific diarylhydantoin and diarylthiohydantoin compounds of formula (I) where X is S or O, and when X is S then R1 is OH or NH2; and when X is O then R1 is OH, NH2 or NHMe; or salts or solvates thereof. Isolated and purified forms of the compounds are also described, as are unit dosage forms, compositions comprising substantially pure compound and kits comprising the compounds. The compounds and pharmaceutical compositions thereof may find use in the prevention and/or treatment of medical conditions, including prostate cancer, Parkinson’s disease, Alzheimer’s disease, and others. Compounds of the disclosure include: 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluorobenzoic acid 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluorobenzamide 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-yl)-2-fluorobenzamide 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-2,4- dioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-yl)-2-fluorobenzoic acid
Patent NZ-597600-A (NZ)
Title: Glycopolysialylation of non-blood coagulation proteins
Inventor: JAIN SANJAY
IPC: A61K47/48
Filed: 2010-07-26
Abstract: Disclosed is a method of conjugating polysialic acid (PSA) or a modified PSA (mPSA) to an oxidized carbohydrate moiety of a glycoprotein other than a blood coagulation protein comprising a carbohydrate group, comprising contacting the oxidized carbohydrate moiety with the PSA or mPSA under conditions that allow conjugation, wherein said PSA or mPSA contains an aminooxy group and an oxime linkage is formed between the oxidized carbohydrate moiety and the aminooxy group on the PSA or mPSA. Disclosed is a conjugated glycoprotein other than a blood coagulation protein comprising: (a) the glycoprotein; and (b) at least one aminooxy-PSA or -mPSA bound to the glycoprotein of (a), wherein said aminooxy-PSA or -mPSA is attached to the glycoprotein via one or more carbohydrate moieties.
Patent NZ-600047-A (NZ)
Title: Briquette iron by hot molding and process for producing the same
Inventor: SUGIYAMA TAKESHI
IPC: C21B13/00
Filed: 2007-11-07
Abstract: 600047 Disclosed herein is a hot briquette iron, suitable as a raw material to be charged in a blast furnace, comprising a plurality of reduced iron particles which are bonded to each other by hot forming, wherein the reduced iron particles each have a surface region having an average carbon content of 0.1 to 2.5% by mass and a central region positioned inside the surface region and having an average carbon content higher than that of the surface region, where the surface region is the region from the surface to a depth of 3mm. The particles as a whole have an average carbon content of 1.0 to 5.0%.
Patent NZ-603098-A (NZ)
Title: Crate
Inventor: ORGELDINGER WOLFGANG
IPC: B65D6/00
Filed: 2011-03-28
Abstract: 603098 Disclosed is A crate (100) comprising a bottom and two respective pairwise opposing side walls (120) and two respective pairwise opposing end walls (130). Each side wall comprises a plurality of vent holes in a region (see A, figure 1) extending along a horizontal direction (see 101, figure 1) of the side wall. Each end wall comprises a grip hole (135). The region (A) is a distance (see dA, figure 5) away from a corner (see 505, figure 5) of the crate, the distance (dA) being equal to the distance (see dGH, figure 5) the grip hole is away from the same corner of the crate. A height (hA) of the region (A) is equal to the height (hGH) of the grip hole. This is such, that when crates are stacked perpendicularly, at the same height, the side vent holes of one crate aligns with the grip hole of another crate to allow ventilation between perpendicularly arranged crates.
Patent NZ-614879-A (NZ)
Title: Heterocyclic modulators of lipid synthesis
Inventor: OSLOB JOHAN D
IPC: C07D491/10
Filed: 2012-03-08
Abstract: Compounds of structure IX that are fatty acid synthesis modulators are provided. The compounds may be used to treat disorders characterized by disregulation of the fatty acid synthase function by modulating the function and/or the fatty acid synthase pathway. Methods are provided for treating such disorders including viral infections, such as hepatits C infection, cancer and metabolic disorders.
Patent NZ-616345-A (NZ)
Title: 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one for use in the treatment of adenoid cystic carcinoma
Inventor: SHI MICHAEL
IPC: A61P35/00
Filed: 2012-05-18
Abstract: Disclosed is the use of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one (also known as dovitinib and TKI-258) or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for the treatment of adenoid cystic carcinoma wherein the medicament is adapted for administration with docetaxel and a pharmaceutically acceptable carrier.
Patent NZ-616860-A (NZ)
Title: Lockout device
Inventor: WOJTAK RAY
IPC: H01H9/28
Filed: 2012-04-25
Abstract: Disclosed is a circuit breaker lockout device for assembly with an instrument includes a housing and security cover to prevent operation of the instrument. The circuit breaker lockout device for assembly with a circuit breaker has a base portion, a neck portion extending in a longitudinal direction from the base portion, and a head portion extending in a lateral direction from a distal end of the neck portion. The lockout device comprises a housing including a side wall at least partially defining an internal cavity sized to receive the head portion of the instrument, and a protrusion extending from an internal surface of the side wall and positioned to retain the head portion within the internal cavity when the head portion of the instrument is received in the internal cavity. The housing defines an opening having a laterally facing first portion sized to receive the head portion of the instrument and a downwardly facing second portion sized to receive the neck portion of the instrument. A plate cover is assembled with the housing and slideable with respect to the housing in the longitudinal direction between a lockout position at least partially blocking the first portion of the opening to secure the head portion of the instrument within the internal cavity, and a release position permitting withdrawal of the head portion of the instrument through the first portion of the opening. A lock interface is configured for securing the cover in the lockout position.
Patent NZ-617353-A (NZ)
Title: Anticancer fusion protein
Inventor: PIECZYKOLAN JERZY SZCZEPAN
IPC: A61K38/17
Filed: 2012-04-19
Abstract: A fusion protein comprising: domain (a) which comprises the functional fragment of a soluble hTRAIL protein sequence starting with an amino acid in a position not lower than hTRAIL95, or a homolog of said functional fragment having at least 70% sequence identity; and at least one domain (b) which is the sequence of an effector peptide having anti-proliferative activity against tumour cells, and wherein the sequence of domain (b) is attached at the C-terminus and/or at the N-terminus of domain (a). Also disclosed is the use of said fusion protein for the treatment of cancer.
Patent NZ-619717-A (NZ)
Title: Aluminium smelter comprising electrical conductors made from a superconducting material
Inventor: BARDET Benoit
IPC: C25C3/20
Filed: 2012-07-10
Abstract: The invention relates to an aluminium smelter (1). The aluminium smelter comprises (i) a series of electrolytic cells (2) intended for the production of aluminium, forming one or more rows. (ii) A power-feeding station (12) intended to supply the series of electrolytic cells (2) with electrolysis current (I1), the power-feeding station (12) comprising two poles. (iii) A main electric circuit (15) through which the electrolysis current (I1) flows, said circuit having two ends each connected to one of the poles of the power-feeding station (12). (iv) At least one secondary electric circuit (16) comprising an electrical conductor made from a superconducting material, through which a current (I2) flows, and extending alongside the rows of electrolytic cells (2). The aluminium smelter is characterised in that the superconducting electrical conductor of the secondary electric circuit (16) extends alongside the rows of electrolytic cells (2) at least twice, thereby forming multiple turns in series.
Patent NZ-619873-A (NZ)
Title: Methods and compositions for treating asthma using anti-il-13 antibodies
Inventor: TRIPP CATHERINE
IPC: A61P11/06
Filed: 2012-07-02
Abstract: Disclosed is an isolated composition comprising an anti-IL-13 antibody, or antigen binding portion thereof, wherein, when administered intravenously to a subject at a dose of about 0.3 mg/kg, 1 mg/kg, 3 mg/kg or 10 mg/kg, the antibody, or antigen-binding portion thereof, is capable of exhibiting any of the pharmacokinetic parameters set forth in the specification, Tables or Figures. Also disclosed is an isolated composition comprising an anti-IL-13 antibody, or antigen binding portion thereof, wherein, when administered subcutaneously to a subject at a dose of about 0.3 mg/kg, 1 mg/kg or 3 mg/kg, the antibody, or antigen-binding portion thereof, is capable of exhibiting any of the pharmacokinetic parameters set forth in the specification, Tables or Figures.
Patent NZ-621752-A (NZ)
Title: Systems and methods to increase rigidity and snag-resistance of catheter tip
Inventor: SHEVGOOR SIDDARTH K
IPC: A61M25/00
Filed: 2012-08-07
Abstract: A venous catheter having a catheter tip comprising recessed (248) diffusion holes (250,251) for increasing the snag-resistance of the venous catheter. Also disclosed are systems and methods for providing axial ridges (266) interposed between diffusion holes for increasing the rigidity of the vented catheter tip. By having the apertures within such portions recessed from the outer surface of the catheter tip snag-resistance is enhanced.
Patent NZ-627527-A (NZ)
Title: Method and system for measurement of resource meters
Inventor: SANKEY JOHN TODD
IPC: G01R22/00
Filed: 2013-01-10
Abstract: Disclosed is a method for measurement of resource meters (102). The method includes receiving, from each of multiple site aggregation units (104), site aggregation data comprising aggregated resource measurements from at least one of the resource meters (102) and a site aggregation digest that substantially uniquely identifies the resource measurements. The site aggregation data from all the site aggregation units (104) comprise aggregated resource measurements from all of the resource meters (102). The site aggregation digests received from the multiple site aggregation units (104) are then stored and aggregated into central aggregation data. The data is then transmitted to a resource distributor.